These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 35304794

  • 1. Presentation and outcomes of post-transplant lymphoproliferative disorder at a single institution pediatric transplant center.
    Ramos-Gonzalez G, Crum R, Allain A, Agur T, O'Melia L, Staffa S, Burchett SK, Siegele B, Weinberg O, Rodig NM, Fawaz R, Singh TP, Freiberger DA, Bae Kim H.
    Pediatr Transplant; 2022 Aug; 26(5):e14268. PubMed ID: 35304794
    [Abstract] [Full Text] [Related]

  • 2. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders.
    Afify ZAM, Taj MM, Orjuela-Grimm M, Srivatsa K, Miller TP, Edington HJ, Dalal M, Robles J, Ford JB, Ehrhardt MJ, Ureda TJ, Rubinstein JD, McCormack S, Rivers JM, Chisholm KM, Kavanaugh MK, Bukowinski AJ, Friehling ED, Ford MC, Reddy SN, Marks LJ, Smith CM, Mason CC.
    Cancer; 2023 Mar 01; 129(5):780-789. PubMed ID: 36571557
    [Abstract] [Full Text] [Related]

  • 3. Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.
    Ganne V, Siddiqi N, Kamaplath B, Chang CC, Cohen EP, Bresnahan BA, Hariharan S.
    Clin Transplant; 2003 Oct 01; 17(5):417-22. PubMed ID: 14703923
    [Abstract] [Full Text] [Related]

  • 4. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
    Chen DB, Wang Y, Song QJ, Shen DH.
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep 01; 41(9):607-12. PubMed ID: 23157829
    [Abstract] [Full Text] [Related]

  • 5. CD20 expression predicts survival in paediatric post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation.
    Orjuela MA, Alobeid B, Liu X, Siebert AL, Kott ER, Addonizio LJ, Morris E, Garvin JH, Lobritto SJ, Cairo MS.
    Br J Haematol; 2011 Mar 01; 152(6):733-42. PubMed ID: 21275950
    [Abstract] [Full Text] [Related]

  • 6. A single-center experience of post-transplant lymphoproliferative disorder (PTLD) cases after pediatric liver transplantation: Incidence, outcomes, and association with food allergy.
    Barış Z, Özçay F, Yılmaz Özbek Ö, Haberal N, Sarıalioğlu F, Haberal M.
    Turk J Gastroenterol; 2018 May 01; 29(3):354-360. PubMed ID: 29755021
    [Abstract] [Full Text] [Related]

  • 7. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
    Muchtar E, Kramer MR, Vidal L, Ram R, Gurion R, Rosenblat Y, Bakal I, Shpilberg O.
    Transplantation; 2013 Oct 15; 96(7):657-63. PubMed ID: 23823652
    [Abstract] [Full Text] [Related]

  • 8. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
    Trappe R, Oertel S, Leblond V, Mollee P, Sender M, Reinke P, Neuhaus R, Lehmkuhl H, Horst HA, Salles G, Morschhauser F, Jaccard A, Lamy T, Leithäuser M, Zimmermann H, Anagnostopoulos I, Raphael M, Riess H, Choquet S, German PTLD Study Group, European PTLD Network.
    Lancet Oncol; 2012 Feb 15; 13(2):196-206. PubMed ID: 22173060
    [Abstract] [Full Text] [Related]

  • 9. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Allen UD, Preiksaitis JK, AST Infectious Diseases Community of Practice.
    Clin Transplant; 2019 Sep 15; 33(9):e13652. PubMed ID: 31230381
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb 15; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 11. Incidence and outcomes of post-transplant lymphoproliferative disease after 5365 solid-organ transplants over a 20-year period at two UK transplant centres.
    Santarsieri A, Rudge JF, Amin I, Gelson W, Parmar J, Pettit S, Sharkey L, Uttenthal BJ, Follows GA.
    Br J Haematol; 2022 May 15; 197(3):310-319. PubMed ID: 35235680
    [Abstract] [Full Text] [Related]

  • 12. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar 15; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathologic characteristics of post-transplant lymphoproliferative disorders.
    Nalesnik MA.
    Recent Results Cancer Res; 2002 Mar 15; 159():9-18. PubMed ID: 11785849
    [Abstract] [Full Text] [Related]

  • 14. Post-transplant lymphoproliferative disorders.
    Singavi AK, Harrington AM, Fenske TS.
    Cancer Treat Res; 2015 Mar 15; 165():305-27. PubMed ID: 25655616
    [Abstract] [Full Text] [Related]

  • 15. Risk factors evaluation of post-transplant lymphoproliferative disorders after allogeneic haematopoietic stem cell transplantation with comparison between paediatric and adult.
    Chen DB, Liu XY, Kong FZ, Jiang Q, Shen DH.
    J Clin Pathol; 2021 Nov 15; 74(11):697-703. PubMed ID: 34011618
    [Abstract] [Full Text] [Related]

  • 16. Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients.
    Reams BD, McAdams HP, Howell DN, Steele MP, Davis RD, Palmer SM.
    Chest; 2003 Oct 15; 124(4):1242-9. PubMed ID: 14555552
    [Abstract] [Full Text] [Related]

  • 17. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia.
    Weintraub L, Weiner C, Miloh T, Tomaino J, Joashi U, Benchimol C, Strauchen J, Roth M, Wistinghausen B.
    J Pediatr Hematol Oncol; 2014 Nov 15; 36(8):e481-6. PubMed ID: 24878618
    [Abstract] [Full Text] [Related]

  • 18. Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation.
    Chen DB, Song QJ, Chen YX, Chen YH, Shen DH.
    Int J Hematol; 2013 Jan 15; 97(1):117-24. PubMed ID: 23255160
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P, ESCMID Study Group of Infection in Compromised Hosts.
    Clin Microbiol Infect; 2014 Sep 15; 20 Suppl 7():109-18. PubMed ID: 24475976
    [Abstract] [Full Text] [Related]

  • 20. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
    Romero S, Montoro J, Guinot M, Almenar L, Andreu R, Balaguer A, Beneyto I, Espí J, Gómez-Codina J, Iacoboni G, Jarque I, López-Andújar R, Mayordomo-Aranda E, Montalar J, Pastor A, Pastor M, Piñana JL, Rojas-Ferrer N, Sánchez-Lázaro I, Sandoval J, Sanz G, Sanz MÁ, Solé A, Sanz J.
    Leuk Lymphoma; 2019 Jan 15; 60(1):142-150. PubMed ID: 29966464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.